Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | — | 10.9B | 11.1B | 10.5B |
Cost of revenue | 7.1B | 6.7B | 6.7B | 6.0B |
Gross profit | — | 4.2B | 4.4B | 4.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.5B | 1.6B | 1.5B | 1.3B |
Operating income | — | 1.4B | 1.7B | 1.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | 27.9M | 44.0M | 26.7M |
Other income expense | — | — | — | — |
Pretax income | — | 1.5B | 1.8B | 2.1B |
Tax provision | — | 403.4M | 493.3M | 538.2M |
Net income | 713.7M | 1.1B | 1.3B | 1.6B |
Basic EPS | — | 101.0 | 118.8 | 139.5 |
Diluted EPS | — | 101.0 | 118.8 | 139.5 |
Basic average shares | — | 11.3M | 11.3M | 11.3M |
Diluted average shares | — | 11.3M | 11.3M | 11.3M |
EBITDA | — | 1.7B | 2.0B | 2.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | — | 0 | 0 | 0 |